Public Sector Pension Investment Board (PSP Investments)’s Albany Molecular Research Inc AMRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-11,528
Closed -$250K 1451
2017
Q2
$250K Sell
11,528
-4,100
-26% -$74.4K ﹤0.01% 1209
2017
Q1
$219K Hold
15,628
﹤0.01% 1249
2016
Q4
$293K Hold
15,628
﹤0.01% 1222
2016
Q3
$258K Sell
15,628
-3,000
-16% -$44.4K ﹤0.01% 1204
2016
Q2
$250K Hold
18,628
﹤0.01% 1192
2016
Q1
$285K Hold
18,628
﹤0.01% 1127
2015
Q4
$370K Sell
18,628
-11,000
-37% -$209K ﹤0.01% 1095
2015
Q3
$516K Sell
29,628
-7,100
-19% -$145K ﹤0.01% 1103
2015
Q2
$743K Sell
36,728
-8,200
-18% -$158K 0.01% 1131
2015
Q1
$791K Buy
44,928
+628
+1% +$10.7K 0.01% 1137
2014
Q4
$721K Hold
44,300
﹤0.01% 1166
2014
Q3
$978K Buy
44,300
+2,400
+6% +$49.1K 0.01% 1101
2014
Q2
$843K Buy
+41,900
New +$710K 0.01% 1171

Other funds holding AMRI

Public Sector Pension Investment Board (PSP Investments)'s AMRI Position: Q3 2017 in Review

Public Sector Pension Investment Board (PSP Investments) sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 11,528 shares — an estimated $250K sold.

Public Sector Pension Investment Board (PSP Investments) first reported a position in AMRI in Q2 2014 and held it in 13 quarters. The position peaked at $978K in Q3 2014. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Public Sector Pension Investment Board (PSP Investments) reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Public Sector Pension Investment Board (PSP Investments) sold 11,528 Albany Molecular Research Inc shares in Q3 2017, an estimated $250K.
  • Public Sector Pension Investment Board (PSP Investments) first reported a position in Albany Molecular Research Inc in Q2 2014 and held it in 13 quarters.
  • Public Sector Pension Investment Board (PSP Investments)'s Albany Molecular Research Inc position peaked at $978K in Q3 2014.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Public Sector Pension Investment Board (PSP Investments)'s 13F filing for Q3 2017, filed 14 Nov 2017.